Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 95,581,848
  • Shares Outstanding, K 1,245,853
  • Annual Sales, $ 27,116 M
  • Annual Income, $ 5,665 M
  • 60-Month Beta 0.18
  • Price/Sales 3.48
  • Price/Cash Flow 8.48
  • Price/Book 5.20
Trade GILD with:

Options Overview Details

View History
  • Implied Volatility 20.80% ( -0.42%)
  • Historical Volatility 24.29%
  • IV Percentile 28%
  • IV Rank 24.87%
  • IV High 33.98% on 08/05/24
  • IV Low 16.44% on 12/05/23
  • Put/Call Vol Ratio 0.57
  • Today's Volume 13,872
  • Volume Avg (30-Day) 18,494
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 230,953
  • Open Int (30-Day) 282,792

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 1.66
  • Number of Estimates 12
  • High Estimate 1.95
  • Low Estimate 1.45
  • Prior Year 2.29
  • Growth Rate Est. (year over year) -27.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.42 +7.42%
on 07/24/24
78.45 -2.21%
on 07/30/24
+5.55 (+7.80%)
since 07/23/24
3-Month
62.07 +23.60%
on 05/31/24
78.45 -2.21%
on 07/30/24
+10.55 (+15.94%)
since 05/23/24
52-Week
62.07 +23.60%
on 05/31/24
87.86 -12.68%
on 01/19/24
-0.32 (-0.42%)
since 08/23/23

Most Recent Stories

More News
3 Stocks Retirees Should Absolutely Love

All of these stocks can provide steady income to retired investors.

ABT : 112.69 (+0.53%)
ABBV : 197.55 (+0.60%)
BMY : 48.11 (+1.03%)
GILD : 76.72 (+1.08%)
Stocks Close Higher as Market Sentiment Improves

The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.54%. US stocks settled...

$SPX : 5,634.61 (+1.15%)
SPY : 562.13 (+1.06%)
$DOWI : 41,175.08 (+1.14%)
DIA : 411.83 (+1.07%)
$IUXX : 19,720.87 (+1.18%)
QQQ : 480.00 (+1.08%)
ZNU24 : 113-225s (+0.36%)
AKAM : 101.83 (+0.25%)
EXPE : 138.13 (+3.76%)
TTD : 105.00 (+1.77%)
LLY : 952.74 (-0.15%)
TTWO : 159.39 (+0.43%)
Gilead Sciences (GILD) Q2 2024 Earnings Call Transcript

GILD earnings call for the period ending June 30, 2024.

GILD : 76.72 (+1.08%)
Gilead: Q2 Earnings Snapshot

Gilead: Q2 Earnings Snapshot

GILD : 76.72 (+1.08%)
Stock Index Futures Rise After Weekly Job Numbers are Released

September S&P 500 E-Mini futures (ESU24) are down -0.10%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.03% this morning as market participants geared up for U.S. weekly jobless claims data...

ESU24 : 5,652.50s (+1.05%)
NQU24 : 19,790.75s (+1.09%)
SMCI : 613.24 (+1.39%)
ABNB : 116.85 (+1.21%)
CRL : 205.27 (+1.96%)
FTNT : 74.73 (+0.32%)
AXON : 370.70 (-0.53%)
LLY : 952.74 (-0.15%)
GILD : 76.72 (+1.08%)
DDOG : 117.23 (+1.39%)
EXPE : 138.13 (+3.76%)
TTD : 105.00 (+1.77%)
Do Wall Street Analysts Like Gilead Sciences Stock?

Gilead Sciences has underperformed the broader market over the past year, yet Wall Street analysts remain moderately bullish about the stock’s prospects.

GILD : 76.72 (+1.08%)
$SPX : 5,634.61 (+1.15%)
FTXH : 29.38 (+0.74%)
Stocks Set to Open Sharply Lower as Global Market Rout Intensifies

September S&P 500 E-Mini futures (ESU24) are down -2.48%, and September Nasdaq 100 E-Mini futures (NQU24) are down -4.10% this morning, extending last week’s losses as concerns intensified that the Federal...

ESU24 : 5,652.50s (+1.05%)
NQU24 : 19,790.75s (+1.09%)
AAPL : 226.84 (+1.03%)
INTC : 20.54 (+2.19%)
AMZN : 177.04 (+0.52%)
SNAP : 9.43 (+1.95%)
CLX : 153.06 (+1.28%)
DIS : 90.56 (+0.71%)
CAT : 348.41 (+1.77%)
LLY : 952.74 (-0.15%)
PLTR : 31.78 (-0.44%)
GILD : 76.72 (+1.08%)
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off

Dividend stocks are great; cheap dividend stocks are better.

ABT : 112.69 (+0.53%)
GILD : 76.72 (+1.08%)
Canadians Enjoy Shortened Week

Monday U.S. Economic Lookahead S&P final U.S. services PMI (July) ...

CFF.TO : 0.3900 (-4.88%)
KBL.TO : 37.56 (+1.10%)
GWO.TO : 43.59 (+0.21%)
CSX : 33.69 (+1.38%)
PLTR : 31.78 (-0.44%)
ITUB : 6.70 (+1.82%)
AMGN : 328.80 (+1.32%)
CAT : 348.41 (+1.77%)
UBER : 74.30 (+1.35%)
DIS : 90.56 (+0.71%)
MCK : 552.15 (-1.56%)
SHOP : 76.14 (+2.48%)
Option Volatility And Earnings Report For July 29 – August 2

This week we have Apple, Advanced Micro Devices, Amazon, Pfizer, Coinbase, Meta Platforms, Intel, Exxon Mobil, Boeing, PayPal, Starbucks, McDonald’s and Chevron all set to report.

AAPL : 226.84 (+1.03%)
AMD : 154.98 (+2.16%)
AMZN : 177.04 (+0.52%)
PFE : 28.90 (+0.42%)
COIN : 211.40 (+6.54%)
META : 528.00 (-0.74%)
INTC : 20.54 (+2.19%)
XOM : 116.32 (+1.39%)
BA : 174.96 (+1.27%)
PYPL : 71.70 (+0.25%)
SBUX : 94.02 (+1.72%)
MCD : 289.52 (+0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya,...

See More

Key Turning Points

3rd Resistance Point 78.47
2nd Resistance Point 77.79
1st Resistance Point 77.26
Last Price 76.72
1st Support Level 76.05
2nd Support Level 75.37
3rd Support Level 74.84

See More

52-Week High 87.86
Fibonacci 61.8% 78.01
Last Price 76.72
Fibonacci 50% 74.97
Fibonacci 38.2% 71.92
52-Week Low 62.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar